Stockwatch

Date	Sym	Type	Headline
2024-04-24 09:00	UU:TTOO	News Release200	T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
2024-04-11 16:05	UU:TTOO	News Release200	T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
2024-03-28 09:00	UU:TTOO	News Release200	T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
2024-03-20 07:30	UU:TTOO	News Release200	T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
2024-03-19 09:00	UU:TTOO	News Release200	T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
2024-03-18 09:00	UU:TTOO	News Release200	T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
2024-03-12 09:00	UU:TTOO	News Release200	T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
2024-02-15 16:06	UU:TTOO	News Release200	T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
2024-02-15 16:04	UU:TTOO	News Release200	T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
2024-02-15 16:02	UU:TTOO	News Release200	T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
2024-02-12 09:00	UU:TTOO	News Release200	T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
2024-02-07 16:05	UU:TTOO	News Release200	T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024
2024-02-07 09:00	UU:TTOO	News Release200	U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize
2024-01-18 09:00	UU:TTOO	News Release200	T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients
2024-01-03 09:00	UU:TTOO	News Release200	T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing
2023-11-03 09:00	UU:TTOO	News Release200	T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
2023-11-01 09:00	UU:TTOO	News Release200	T2 Biosystems Regains Compliance with Nasdaq Listing Requirements
2023-10-24 16:05	UU:TTOO	News Release200	T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
2023-10-23 09:00	UU:TTOO	News Release200	T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
2023-10-12 16:05	UU:TTOO	News Release200	T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
2023-10-12 16:02	UU:TTOO	News Release200	T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii
2023-10-12 09:00	UU:TTOO	News Release200	T2 Biosystems Announces Reverse Stock Split Effective Today
2023-10-06 16:08	UU:TTOO	News Release200	T2 Biosystems Reports Granting of Inducement Award
2023-10-05 16:05	UU:TTOO	News Release200	T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023
2023-09-19 09:00	UU:TTOO	News Release200	T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel
2023-09-15 16:05	UU:TTOO	News Release200	T2 Biosystems Reports Granting of Inducement Award
2023-09-07 16:05	UU:TTOO	News Release200	T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase
2023-08-28 08:30	UU:TTOO	News Release200	T2 Biosystems Praises CDC ¢ € ™s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs
2023-08-09 08:30	UU:TTOO	News Release200	T2 Biosystems Regains Compliance with Nasdaq ¢ € ™s Market Value of Listed Securities Requirement
2023-08-07 16:05	UU:TTOO	News Release200	T2 Biosystems Announces Second Quarter 2023 Financial Results
2023-07-31 08:30	UU:TTOO	News Release200	T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements
2023-07-28 08:30	UU:TTOO	News Release200	T2 Biosystems to Attend Upcoming Investor Conferences
2023-07-24 16:05	UU:TTOO	News Release200	T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023
2023-07-21 16:05	UU:TTOO	News Release200	T2 Biosystems Reports Granting of Inducement Award
2023-07-20 08:30	UU:TTOO	News Release200	T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
2023-07-12 08:30	UU:TTOO	News Release200	T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results
2023-07-06 08:00	UU:TTOO	News Release200	T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity
2023-06-09 09:15	UU:TTOO	News Release200	T2 Biosystems Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use
2023-06-05 09:00	UU:TTOO	News Release200	T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
2023-05-30 09:00	UU:TTOO	News Release200	T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History
2023-05-23 08:05	UU:TTOO	News Release200	T2 Biosystems Announces First Quarter 2023 Financial Results
2023-05-23 08:01	UU:TTOO	News Release200	T2 Biosystems Announces Exploration of Strategic Alternatives and the Implementation of a Restructuring Program
2023-05-23 08:00	UU:TTOO	News Release200	T2 Biosystems Announces FDA 510(k) Submission for the T2Biothreat Panel
2023-05-22 08:15	UU:TTOO	News Release200	T2 Biosystems Reschedules First Quarter 2023 Financial Results Reporting to May 23, 2023
2023-05-19 09:23	UU:TTOO	News Release200	WBB Research Institute Webcast Highlighted the Need For a Global Response to Candida auris and Other Deadly Antimicrobial Resistant Pathogens
2023-05-17 16:05	UU:TTOO	News Release200	T2 Biosystems Reschedules First Quarter 2023 Financial Results Reporting to May 22, 2023
2023-05-15 16:05	UU:TTOO	News Release200	T2 Biosystems Postpones Reporting of First Quarter 2023 Financial Results